Women’s Knowledge of Genomic Testing and Precision Medicine in Breast Cancer Treatment Decision-Making

Breast cancer (BC) surgery can be considered preference sensitive in that women diagnosed with the disease may have choices to make regarding their treatment. For example, there may be two or more surgical treatment options that are equally effective (Baliski & Hamm, 2020). Because of the opportunity to weigh in on treatment options, there has been an active effort to increase shared decision-making, particularly for women with early-stage cancer (Shickh et al., 2023).